Intratumoral Immunotherapy for Cancer: Update 2024 of a Novel Approach

7 Views
Published
David G. Bostwick, MD, MBA, FCAP, Triopsy Medical, LLC, Orlando, Florida, discusses the potential of intratumoral immunotherapy in treating prostate cancer and other challenging malignancies. In this 19-minute presentation, Dr. Bostwick explores multiplex immunotherapy as a promising avenue for traditionally immunologically resistant cancers like prostate cancer. His presentation inspires optimism for advancing treatment strategies through innovative immune-based approaches.
Category
Oncology
Be the first to comment